Search Results

Stroke after initiation of interferon-beta treatment for relapsing-remitting disseminated white matter disease

Source: Acta Neurologica Scandinavica, Volume 120, Number 6, December 2009 , pp. 453-453(1)

Publisher: Blackwell Publishing

Monoclonal Antibodies in the Treatment of Multiple Sclerosis

Authors: Pauli, F. D.; Berger, T.; Reindl, M.

Source: Current Medicinal Chemistry, Volume 16, Number 36, December 2009 , pp. 4858-4868(11)

Publisher: Bentham Science Publishers

Plasma levels of 15d-PGJ₂ are not altered in multiple sclerosis

Authors: Comabella, M.; Pradillo, J. M.; Fernández, M.; Río, J.; Lizasoain, I.; Julià, E.; Moro, M. A.; Sastre-Garriga, J.; Montalban, X.

Source: European Journal of Neurology, Volume 16, Number 11, November 2009 , pp. 1197-1201(5)

Publisher: Blackwell Publishing

Interferon-β link to depression challenged

Source: Reactions, Volume 1, Number 1274, 2009-10-17 , pp. 4-4(1)

Publisher: Adis International

Morning, rather than evening, injections of interferon-β may lessen flu-like syndrome in patients with multiple sclerosis

Source: Reactions, Volume 1, Number 1275, 2009-10-24 , pp. 5-5(1)

Publisher: Adis International

Interferon β-1b: Panniculitis mimicking appendicitis: case report

Source: Reactions, Volume 1, Number 1271, 2009-09-26 , pp. 22-23(2)

Publisher: Adis International

Lack of interferon-beta bioactivity is associated with the occurrence of relapses in multiple sclerosis

Authors: van der Voort, L. F.; Visser, A.; Knol, D. L.; Oudejans, C. B. M.; Polman, C. H.; Killestein, J.

Source: European Journal of Neurology, Volume 16, Number 9, September 2009 , pp. 1049-1052(4)

Publisher: Blackwell Publishing

Is -interferon a promising therapeutic option for the management of hepatitis C?

Authors: Hosseini-Moghaddam, Seyed Mohammadmehdi; Mousavi, Afkham; Alavian, Seyed Moayed

Source: Journal of Antimicrobial Chemotherapy, Volume 63, Number 6, 30 June 2009 , pp. 1097-1103(7)

Publisher: Oxford University Press

Interferon-β/methylprednisolone: Autoimmune hepatitis: case report

Source: Reactions, Volume 1, Number 1254, 2009-05-30 , pp. 27-27(1)

Publisher: Adis International

Interferon-induced Mx proteins in brain tissue of multiple sclerosis patients

Authors: Al-Masri, A. N.; Heidenreich, F.; Walter, G. F.

Source: European Journal of Neurology, Volume 16, Number 6, June 2009 , pp. 721-726(6)

Publisher: Blackwell Publishing

Differential Activation of Dendritic Cells by Toll-like Receptor Agonists Isolated from the Gram-positive Vaccine Vector Streptococcus gordonii

Authors: Mayer, M. L.; Phillips, C. M.; Townsend, R. A.; Halperin, S. A.; Lee, S. F.

Source: Scandinavian Journal of Immunology, Volume 69, Number 4, April 2009 , pp. 351-356(6)

Publisher: Blackwell Publishing

Interferon-β: Cerebral vasculitis: case report

Source: Reactions, Volume 1, Number 1241, 2009-02-28 , pp. 28-28(1)

Publisher: Adis International

Interferon-Beta Therapy Monitoring in Multiple Sclerosis Patients

Authors: Sottini, A.; Capra, R.; Serana, F.; Chiarini, M.; Caimi, L.; Imberti, L.

Source: Endocrine, Metabolic & Immune Disorders - Drug Targets(Formerly Current Dru, Volume 9, Number 1, March 2009 , pp. 14-28(15)

Publisher: Bentham Science Publishers

Various drugs: Drug-induced liver injury (first report with nystatin, temozolomide and xl-999): 24 case reports

Source: Reactions, Volume 1, Number 1237, 2009-01-31 , pp. 21-22(2)

Publisher: Adis International

Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis

Authors: Putzki, N.; Kollia, K.; Woods, S.; Igwe, E.; Diener, H. C.; Limmroth, V.

Source: European Journal of Neurology, Volume 16, Number 3, March 2009 , pp. 424-426(3)

Publisher: Blackwell Publishing

Management of patients with neutralizing antibodies against interferon-beta: stop IFN-beta therapy or wait for the antibodies to go away?

Author: Sorensen, P. S.

Source: European Journal of Neurology, Volume 16, Number 1, January 2009 , pp. 1-2(2)

Publisher: Blackwell Publishing

Methylprednisolone does not restore biological response in multiple sclerosis patients with neutralizing antibodies against interferon-β

Authors: Hesse, D.; Frederiksen, J. L.; Koch-Henriksen, N.; Schreiber, K.; Stenager, E.; Heltberg, A.; Ravnborg, M.; Bendtzen, K.; Sellebjerg, F.; Sorensen, P. S.

Source: European Journal of Neurology, Volume 16, Number 1, January 2009 , pp. 43-47(5)

Publisher: Blackwell Publishing

Interferon-β: Sclerosing skin disorders in patients with multiple sclerosis?: 3 case reports

Source: Reactions, Volume 1, Number 1234, 2009-01-10 , pp. 24-24(1)

Publisher: Adis International

Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis

Authors: Putzki, N.; Pfriem, A.; Limmroth, V.; Yaldizli, Ö.; Tettenborn, B.; Diener, H. C.; Katsarava, Z.

Source: European Journal of Neurology, Volume 16, Number 2, February 2009 , pp. 262-267(6)

Publisher: Blackwell Publishing

Impression of Clinical Worsening Fails to Predict Interferon-β Neutralizing Antibody Status

Authors: Rot, U.; Sominanda, A.; Fogdell-Hahn, A.; Hillert, J.

Source: The Journal of International Medical Research, Volume 36, Number 6, November 2008 , pp. 1418-1425(8)

Publisher: Field House Publishing